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Alteration of the Diastereoselectivity of 3-Methylaspartate
Ammonia Lyase by Using Structure-Based Mutagenesis
Hans Raj,[a] Barbara Weiner,[b] Vinod Puthan Veetil,[a] Carlos R. Reis,[a] Wim J. Quax,[a]
Dick B. Janssen,[c] Ben L. Feringa,[b] and Gerrit J. Poelarends*[a]
Introduction
3-Methylaspartate ammonia-lyase (MAL) catalyzes the reversi-
ble amination of mesaconate (1) to give (2S,3S)-3-methylas-
partic acid (2) as a major product and (2S,3R)-3-methylaspartic
acid (3) as a minor product (Scheme 1).[1, 2] The enzyme is used
by the anaerobic bacterium Clostridium tetanomorphum as part
of a degradative pathway that converts (S)-glutamic acid via 2
to finally yield acetyl-CoA.[1,2] MAL is of considerable biocatalyt-
ic interest because it also catalyzes the stereo- and regioselec-
tive addition of ammonia to several derivatives of 1 to form a
number of 3-alkyl- and 3-halo-substituted aspartic acids.[3]
Moreover, the broad nucleophile specificity of MAL enables
the use of a range of alternative nucleophiles such as methyla-
mine, ethylamine, hydrazine, and methoxylamine in the conju-
gate addition reaction.[4] These properties make MAL a promis-
ing biocatalyst for the enantiospecific synthesis of both 3- and
N-substituted aspartic acids, which are interesting building
blocks for pharmaceutical synthesis.
MAL is a homodimeric enzyme (molecular mass of
~45.5 kDa) that requires both monovalent (i.e. , K+) and di-
ACHTUNGTRENNUNGvalent (i.e. , MgII) cations for activity.[1, 2] Several studies have
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3-Methylaspartate ammonia-lyase (MAL) catalyzes the reversi-
ble amination of mesaconate to give both (2S,3S)-3-methyl-
ACHTUNGTRENNUNGaspartic acid and (2S,3R)-3-methylaspartic acid as products. The
deamination mechanism of MAL is likely to involve general
base catalysis, in which a catalytic base abstracts the C3
proton of the respective stereoisomer to generate an enolate
anion intermediate that is stabilized by coordination to the es-
sential active-site MgII ion. The crystal structure of MAL in com-
plex with (2S,3S)-3-methylaspartic acid suggests that Lys331 is
the only candidate in the vicinity that can function as a general
base catalyst. The structure of the complex further suggests
that two other residues, His194 and Gln329, are responsible for
binding the C4 carboxylate group of (2S,3S)-3-methylaspartic
acid, and hence are likely candidates to assist the MgII ion in
stabilizing the enolate anion intermediate. In this study, the im-
portance of Lys331, His194, and Gln329 for the activity and
stereoselectivity of MAL was investigated by site-directed mu-
tagenesis. His194 and Gln329 were replaced with either an
ACHTUNGTRENNUNGalanine or arginine, whereas Lys331 was mutated to a glycine,
alanine, glutamine, arginine, or histidine. The properties of the
mutant proteins were investigated by circular dichroism (CD)
spectroscopy, kinetic analysis, and 1H NMR spectroscopy. The
CD spectra of all mutants were comparable to that of wild-
type MAL, and this indicates that these mutations did not
result in any major conformational changes. Kinetic studies
demonstrated that the mutations have a profound effect on
the values of kcat and kcat/KM; this implicates Lys331, His194 and
Gln329 as mechanistically important. The 1H NMR spectra of
the amination and deamination reactions catalyzed by the
mutant enzymes K331A, H194A, and Q329A showed that these
mutants have strongly enhanced diastereoselectivities. In the
amination direction, they catalyze the conversion of mesaco-
nate to yield only (2S,3S)-3-methylaspartic acid, with no detect-
able formation of (2S,3R)-3-methylaspartic acid. The results are
discussed in terms of a mechanism in which Lys331, His194,
and Gln329 are involved in positioning the substrate and in
formation and stabilization of the enolate anion intermediate.
Scheme 1. MAL-catalyzed reversible amination of mesaconate to yield
(2S,3S)- and (2S,3R)-3-methylaspartic acid.
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been aimed at demonstrating the deamination mechanism of
MAL.[5–11] Some of these have suggested that MAL operates
through a carbanion mechanism with rate-limiting CN bond
cleavage.[5,6] This proposed mechanism is supported by the
ACHTUNGTRENNUNGobservation that C3 hydrogen exchange of the C3-deuterated
substrate (2, Scheme 1) with solvent occurs more rapidly than
CN bond cleavage. Moreover, no primary isotope effect was
observed for the deamination of the C3-deuterated sub-
strate.[5, 6] Nonetheless, other reports have questioned this carb-
anion mechanism,[7–11] and up until the structure of MAL was
reported, the catalytic mechanism of the enzyme remained un-
resolved.
The crystal structure of MAL from C. tetanomorphum[12] and
that of the isozyme from Citrobacter amalonaticus[13] were re-
ported a few years ago. These structures showed that within
the functional homodimer, each MAL monomer consists of
two domains (Figure 1A). The larger C-terminal domain is an
eightfold a/b barrel, and the smaller N-terminal domain mainly
consists of b strands. The active site carrying the essential MgII
ion is located in a large cleft between the two domains. Struc-
ture comparisons identified MAL as a member of the enolase
superfamily.[12,13] Despite little sequence identity, the overall a/
b-barrel topology and the active-site architecture of MAL are
strikingly similar to those of enolase, the title enzyme of this
superfamily. Interestingly, the members of the enolase super-
family catalyze different reactions but share a common catalyt-
ic step: the metal-ion-assisted, general-base-catalyzed abstrac-
tion of the a proton of a carboxylic acid substrate to generate
an enzyme-stabilized enolate anion intermediate.[14] On the
basis of the structural homology to the enolase superfamily,
coupled with the earlier results of kinetic isotope studies, it
was proposed that MAL functions by using the common eno-
lase catalytic step, and thus generates and stabilizes an enolate
anion intermediate (4, Scheme 2).[12,13]
Although a general base catalyst for the deamination activity
of MAL has not been determined, Lys331 appears to be a likely
candidate because it occupies a similar position to the general
base Lys345 in enolase.[12,13] Moreover, the crystal structure of
C. amalonaticus MAL in complex with 2 shows that Lys331 is
the only candidate in the vicinity of C3 that can function as a
general base catalyst (Figure 1B).[13] Two other residues, His194
and Gln329, are implicated in binding the C4 carboxylate
group of 2 (Figure 1B),[13] and thus are likely candidates for as-
sisting the MgII ion in stabilizing the enolate anion intermedi-
ate. It was further postulated that His194 might also function
as the second base (in addition to Lys331) that abstracts the
C3 proton of the stereoisomer 3 (Scheme 1).[12]
The objective of the present work is twofold. First, we dem-
onstrate the importance of
His194, Gln329, and Lys331 for
the MAL-catalyzed reactions.
Second, we show that mutations
of these active-site residues alter
the diastereoselectivity of MAL.
This led to a single amino acid
MAL variant (H194A) that has
useful properties for the stereo-
selective synthesis of isomerically pure (2S,3S)-3-methylaspartic
acid. The results are discussed in terms of a mechanism in
Figure 1. A) Ribbon diagram of the functional homodimeric structure of
C. amalonaticus MAL.[13] The location of the active site in each monomer is
indicated by the bound MgII ion, which is shown as a red sphere. The figure
was prepared with PyMOL.[27] B) A close-up of the active site of C. amalona-
ticus MAL in complex with (2S,3S)-3-methylaspartic acid.[13] For clarity, only
the MgII ion (magenta sphere) and the active-site residues His194, Gln329,
and Lys331 are shown. The roles of these residues and their interactions are
discussed in the text. Observed distances (in ) between active site residues
and substrate are indicated. The figure was prepared with PyMOL.[27]
Scheme 2. Proposed enolate anion intermediate along the reaction pathway of MAL.
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which His194, Gln329, and Lys331 are involved in binding and
positioning of the substrate, and in formation and stabilization
of the enolate anion intermediate.
Results
Expression and purification of MAL
The gene coding for MAL was amplified from genomic DNA of
C. tetanomorphum and fused into the start codon of the ex-
pression vector pBAD/Myc-His A, resulting in the construct
pBAD ACHTUNGTRENNUNG(MAL-His). Sequencing of the cloned MAL gene verified
that no mutations had been introduced during the amplifica-
tion and cloning procedures. The MAL gene in pBAD ACHTUNGTRENNUNG(MAL-His)
is under transcriptional control of the araBAD promoter and
the recombinant enzyme was produced upon induction with
arabinose in E. coli TOP10 as a C-terminal hexahistidine fusion
protein. Production of soluble and active MAL was most effi-
cient when cells were cultivated at 17 8C and when 0.004% (w/
v) arabinose was used. The recombinant enzyme was purified
by a one-step Ni-based immobilized metal affinity chromatog-
raphy protocol, which typically provides 10–15 mg of homoge-
neous enzyme per liter of culture.
Kinetic and 1H NMR spectroscopic analysis of the MAL-
catalyzed amination of 1
A mixture containing MAL, mesaconate (1), and ammonium
chloride was monitored by 1H NMR spectroscopy to verify that
the products of the reaction are (2S,3S)-3-methylaspartic acid
(2) and (2S,3R)-3-methylaspartic acid (3), as has been previously
reported.[2] Indeed, the enzymatic amination of 1 yields 2 and
3, as indicated by signals in the NMR spectra consistent with
the structures of these amino acid products (Figure 2A).[15] Al-
though the 1H NMR spectra showed signals for both 2 and 3,
those corresponding to 2 predominated in the initial spectra
whereas signals for 3 appeared only in the later spectra. These
observations confirm that MAL catalyzes the rapid conversion
of 1 to the natural substrate 2, as well as the slow conversion
of 1 to 3. After a 13-day incubation period, the MAL-catalyzed
reaction was complete; the reaction resulted in 45% 2 and
35% 3.
A previously described assay[3] was used to measure the ki-
netic parameters for MAL in the amination direction. Accord-
ingly, the rate of amination of 1 was monitored by following
the depletion of 1 at 270 nm in 500 mm Tris–HCl buffer
(pH 9.0) containing 20 mm MgCl2 and 400 mm NH4Cl at 30 8C.
A kcat of 611 s1 and a KM of 0.70.02 mm were found; this
results in a kcat/KM of ~8.7104m1 s1 (Table 1).
Figure 2. 1H NMR spectra monitoring the amination of 1 by A) MAL and B) the H194A mutant. The 1H NMR signals for compounds 1, 2, and 3 are indicated
(see the Supporting Information for assignment of the signals). Spectra were recorded after 1 h, 7 d, and 13 d, as shown from left to right, respectively. The
1H NMR spectra of the K331A and Q329A mutants (not shown) were comparable to those of the H194A mutant; that is, there was no detectable formation of
3 in the incubation mixtures. The less prominent singlets at d1.20 and 2.11 ppm correspond to impurities resulting from multiple additions of protein.
Table 1. Apparent kinetic parameters for the MAL, K331A, H194A, and
Q329A-catalyzed amination of mesaconic acid (1)[a]
Enzyme kcat [s
1] KM (for 1) [mm] kcat/KM [m
1 s1]
MAL 611 0.70.02 8.7104
K331A n.d. n.d. <0.001
H194A 8.40.3 141 6.0102
Q329A 0.250.02 1.70.2 1.5102
[a] The steady state kinetic parameters were determined in 500 mm Tris–
HCl buffer (pH 9.0) containing 20 mm MgCl2 and 400 mm NH4Cl at 30 8C.
Errors are standard deviations. n.d. , not determined.
2238 www.chembiochem.org  2009 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim ChemBioChem 2009, 10, 2236 – 2245
G. J. Poelarends et al.
Kinetic and 1H NMR spectroscopic analysis of the MAL-
catalyzed deamination of 2
The rate of deamination of 2 by MAL was monitored by follow-
ing the formation of 1 at 240 nm in 500 mm Tris–HCl buffer
(pH 9.0) containing 20 mm MgCl2 and 1 mm KCl at 30 8C.
[3] For
the deamination of 2, a kcat of 894 s1 and a KM of 1.0
0.1 mm were found; this results in a kcat/KM of 8.910
4m1 s1
(Table 2).
A mixture containing MAL and 2 was also monitored by
1H NMR spectroscopy to verify that the product of the reaction
is 1. The enzymatic conversion of 2 yields 1, as indicated by a
singlet at 1.74 ppm and a singlet at 6.28 ppm (Figure S4 in the
Supporting Information), which correspond to the protons at
the C3 methyl group and C2, respectively. In addition, signals
corresponding to 3 are also present. After a 13-day incubation
period, the MAL-catalyzed reaction results in 41% 1 and 2%
3.[16] Hence, 1 is the major product of the MAL-catalyzed con-
version of 2.
1H NMR spectroscopic analysis of the MAL-catalyzed
ACHTUNGTRENNUNGdeamination of 3
1H NMR spectroscopic analysis of the diastereoisomer 3 re-
vealed that the provided material contained 94–95% of the re-
quired diastereoisomer 3 and 5–6% of the unwanted diaste-
reoisomer 2. This finding precluded the use of the material in
kinetic experiments. Nevertheless, it was possible to monitor
the deamination of 3 by 1H NMR spectroscopy and identify the
products of the reaction. The 1H NMR spectra showed the dis-
appearance of signals corresponding to 3 and the appearance
of new signals corresponding to 1 and 2. Signals correspond-
ing to 1 predominated in the initial spectra whereas signals for
2 increased in the later spectra. After a lengthy incubation
period (approximately two weeks), the MAL-catalyzed reaction
was complete; it yielded 1 in 79% and 2 in 12% (Figure S5).
Mutagenesis of His194, Lys331, and Gln329
To investigate the importance of His194, Lys331, and Gln329
for the activity and stereoselectivity of MAL, single site-directed
mutants were constructed in which His194 and Gln329 were
replaced with either an alanine or arginine (H194A, H194R,
Q329A, and Q329R) and Lys331 with a glycine, alanine, gluta-
mine, histidine, or arginine (K331G, K331A, K331Q, K331H, and
K331R). DNA sequencing verified that only the intended muta-
tions had been introduced into each mutant gene. The mu-
tants were overexpressed in E. coli strain TOP10 and purified to
>95% homogeneity (as assessed by SDS-PAGE) by using the
Ni-based immobilized metal affinity chromatography protocol
described for wild-type MAL. The yields (in milligrams of
ACHTUNGTRENNUNGhomogeneous protein per liter of cell culture) of the mutants
varied from 10 to 20 mg.
It was shown by nondenaturing PAGE (data not shown) that
the native molecular mass for each mutant is comparable to
that of wild type; this demonstrates that the oligomeric associ-
ation of the mutants was still intact. The structural integrity of
the mutants was also assessed by circular dichroism (CD). The
CD spectra of the mutants were comparable to that of the
wild type; this indicates that these mutations did not result in
any major conformational changes (Figure S6).
Kinetic and 1H NMR spectroscopic analysis of the
ACHTUNGTRENNUNGdeamination of 2 by the MAL mutants
The activities of the MAL mutants were initially assayed by
using the natural substrate 2. It was found that substitution of
Lys331 by a glycine, alanine, histidine, glutamine, or arginine
essentially abolished enzymatic activity, and this underscores
the importance of this residue for the MAL-catalyzed deamina-
tion of 2. Under the conditions of the kinetic assays, no activity
could be detected for these mutants. Substitution of either
His194 or Gln329 by an arginine also resulted in mutant
ACHTUNGTRENNUNGenzymes that were inactive. The H194A and Q329A mutants,
however, deaminate 2 at a reduced catalytic efficiency
(Table 2). For the H194A mutant, there is a slight (1.8-fold) in-
crease in KM and a ~160-fold decrease in kcat ; this results in a
~290-fold reduction in kcat/KM. For the Q329A mutant, there is
a ~8900-fold decrease in kcat, whereas the KM is not affected.
Hence, this results in a ~8900-fold reduction in kcat/KM.
The deamination activities of the three alanine mutants
(H194A, K331A, and Q329A) were also assessed by 1H NMR
spectroscopy after a lengthy (approximately two weeks) incu-
bation period. With 2, the H194A and Q329A-catalyzed reac-
tions resulted in a 40% yield of 1 and a 3% yield of 3, whereas
the K331A-catalyzed reaction showed only a trace amount of
product (2% 1 and 2% 3).[16] These observations parallel those
of the kinetic assays and suggest that Lys331 is more critical
for the deamination activity of MAL than His194 and Gln329.
pH dependence of the kinetic parameters of MAL and the
H194A mutant by using 2
To determine the pKa of the basic group on the enzyme impor-
tant for catalysis (the presumed general base catalyst) and to
evaluate the effect of the alanine mutation on this pKa, the pH
dependence of the kcat/KM for the MAL and H194A-catalyzed
deamination of 2 was determined over the pH range 6.0–9.5.
The other two alanine mutants, K331A and Q329A, were not
active enough with 2 and thus could not be measured. The
Table 2. Kinetic parameters for the MAL, K331A, H194A, and Q329A-cata-
lyzed deamination of (2S,3S)-3-methylaspartic acid (2)[a]
Enzyme kcat [s
1] KM [mm] kcat/KM [m
1 s1]
MAL 894 1.00.1 8.9104
K331A n.d. n.d. <0.001
H194A 0.550.01 1.80.2 3.1102
Q329A 0.010.001 1.00.1 1.0101
[a] The steady state kinetic parameters were determined in 500 mm Tris–
HCl buffer (pH 9.0) containing 20 mm MgCl2 and 1 mm KCl at 30 8C. Errors
are standard deviations. n.d. , not determined.
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log ACHTUNGTRENNUNG(kcat/KM) versus pH profiles of MAL and H194A both show a
single ascending limb with a slope of one (Figure 3).[17] For
wild-type MAL, a pKa value of 7.80.1 was found. For the
H194A mutant, a pKa value of 8.20.1 was found. Hence,
within the estimated errors, there is no significant effect of the
H194A substitution on the pKa for the ascending limb.
1H NMR spectroscopic analysis of the K331A, H194A, and
Q329A-catalyzed deamination of 3
The deamination of the nonnatural substrate 3 by the alanine
mutants was monitored by 1H NMR spectroscopy. After a
13 day-incubation period, the Q329A-catalyzed reaction result-
ed in a 10% yield of 1. The contaminant 2, which is the natural
substrate for the enzyme, was selectively processed by Q329A
at a much faster rate than for 3. The H194A mutant also pro-
cessed the contaminant 2 (this resulted in a 6% yield of 1),
but showed no detectable activity towards 3. The mixture con-
taining the K331A mutant showed no product.
Kinetic and 1H NMR spectroscopic analysis of the amination
of 1 by the MAL mutants
The kinetic parameters for the amination reactions catalyzed
by the MAL mutants were determined and compared to those
measured for the wild-type MAL-catalyzed amination of 1
(Table 1). For the Q329A mutant, there is a slight increase in KM
(~2.4-fold) and a ~240-fold decrease in kcat, which results in a
~600-fold reduction in kcat/KM. For the H194A mutant, there is
a 20-fold increase in KM and only about a sevenfold decrease in
kcat, which results in a ~140-fold reduction in kcat/KM. Under the
conditions of the kinetic assay, no activity could be detected
for the other mutants (H194R, Q329R, K331G, K331A, K331Q,
K331H, and K331R).
The amination of 1 by the three alanine mutants (H194A,
Q329A, and K331A) was also monitored by 1H NMR spectrosco-
py to identify the diastereoisomeric products of the reaction.
After a 13-day incubation period, the K331A, Q329A, and
H194A-catalyzed reactions resulted in 30%, 58%, and 85% dia-
stereoisomer 2, respectively (Figure 2B; data not shown). Inter-
estingly, and in contrast to the wild-type MAL-catalyzed amina-
tion of 1 (Figure 2A), there was no detectable formation of dia-
stereoisomer 3 in the incubation mixtures. For comparison,
conversion of 35% of 1 by wild-type MAL results in a 19%
yield of 2 and 16% of 3. These observations indicate that the
H194A, Q329A, and K331A mutants have enhanced diastereo-
selectivities and catalyze the highly stereoselective conversion
of 1 to 2, with no detectable conversion of 1 to 3.
Discussion
Previous studies of the stereoselectivity of C. tetanomorphum
MAL indicated that the wild-type enzyme catalyzes the reversi-
ble anti and syn-addition of ammonia to mesaconate (1) to
yield (2S,3S)-3-methylaspartic acid (2) and (2S,3R)-3-methylas-
partic acid (3), respectively.[2,9] The determination of the X-ray
structure of C. amalonaticus MAL in complex with the natural
substrate 2 has provided the essential structural information
for the identification of the substrate interactions within the
enzyme–substrate complex.[13] Guided by the structure of this
complex, we have selected three active site residues in C. teta-
nomorphum MAL[12] for mutagenesis to provide insight into
the structural determinants of the reactivity and stereoselectiv-
ity of MAL.[18] The results of these studies are interpreted here
and discussed in terms of a two-base mechanism, in which the
proton abstraction/addition steps are effected by S and R-spe-
cific general base/acid catalysts juxtaposed on either side of
the (chiral) C3 carbon of the substrate.
We first verified that both 2 and 3 are formed as products of
the MAL-catalyzed amination of 1 by 1H NMR spectroscopy. It
was found that stereoisomer 2 is formed at a rate much faster
than stereoisomer 3 (at equilibrium, the ratio of 2/3 is approxi-
mately 1.3). Second, we confirmed that MAL does not catalyze
the direct epimerization of the two stereoisomers. This was evi-
dent from a prolonged incubation of MAL with 2 ; this yielded
1 as the major product and gave only a trace amount of 3. An-
other notable observation is that the incubation of MAL with 3
Figure 3. The pH dependence of log ACHTUNGTRENNUNG(kcat/KM) for the deamination of 2 by
A) wild-type MAL and B) the H194A mutant. The pKa values are discussed in
the text.
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finally gives 2 (in 12% yield), but only after a significant
amount of 1 accumulates in the reaction mixture. This sug-
gests that MAL first catalyzes the syn-elimination of ammonia
from 3 to yield 1, and this is followed by the anti-addition of
ammonia to 1 to give 2. These observations indicate that the
formation of 2 and 3 as products of the MAL-catalyzed amina-
tion of 1 is not the result of the MAL-catalyzed amination of 1
to 2 followed by the slow direct epimerization of 2 to 3.
Hence, MAL indeed catalyzes the rapid anti-addition and the
much slower syn-addition of ammonia to 1 to give 2 and 3,
ACHTUNGTRENNUNGrespectively.
The crystal structure of
C. amalonaticus MAL in complex
with 2 shows that Lys331 is the
only candidate in the vicinity of
C3 that can function as the S-
specific base/acid catalyst (Fig-
ure 1B).[13] This lysine residue is
conserved in all characterized 3-
methylaspartate ammonia-lyases.
Moreover, a comparison of the
active-site structures of MAL and
enolase shows that Lys331 in
MAL superimposes to within 1 
of the previously identified gen-
eral base Lys345 in enolase.[13] To
assess its role in catalysis, we have mutated Lys331 to a gly-
cine, alanine, histidine, glutamine, or arginine. Examination of
the kinetic properties for these mutants clearly shows that
Lys331 is an essential residue in the MAL-catalyzed reactions
because all five mutations at this position result in a dramatic
loss of activity. (There is a >107-fold drop in the value of kcat/
KM with 2). The mutant enzymes appear to retain an intact
overall structural integrity as shown by CD spectroscopy. It is
therefore reasonable to conclude that Lys331 is crucial for cat-
alysis because it functions as the S-specific base catalyst in the
deamination of 2 and, hence, as the acid catalyst (the conju-
gate acid of Lys331) in the corresponding reverse anti-addition
reaction (Scheme 3).
From the ascending limb of the log (kcat/KM) versus pH pro-
file of MAL, a residue with a pKa of approximately 7.8 that
must be deprotonated for optimal activity, might be the gener-
al base catalyst involved in abstraction of the C3 proton of 2.
Whereas the pKa value of Lys331 in MAL has not been directly
measured by NMR spectroscopy, it can be inferred from these
results that the kinetic pKa value of 7.8 is likely due to Lys331.
In the structure of the MAL-substrate complex, His194 and
Gln329 are hydrogen bonded to the C4 carboxylate group of 2
(Figure 1B).[13] This suggests roles for these residues in binding
the substrate, and possible intermediates, in the reaction
mechanism of MAL. In this study, His194 and Gln329 were mu-
tated to assess their role in catalysis. The best-characterized
mutants are the H194A and Q329A mutants, which have meas-
urable activity and show no significant differences in their CD
spectra compared to that of wild-type MAL. Examination of
the kinetic properties for the two mutants in the deamination
direction (by using 2) shows that there is a small effect on KM
and a much larger effect on kcat. This suggests important roles
for His194 and Gln329 in catalysis. The somewhat larger effect
of these mutations on the value of KM in the amination direc-
tion might suggest a more important role for His194 and
Gln329 in binding 1 than 2.
A major part of the loss in activity of the H194A and Q329A
mutants is likely due to the removal of optimal hydrogen-
bonding interactions with the proposed enolate anion inter-
mediate formed at the C4 carbonyl position of 2 (or 1 in the
corresponding reverse reaction); this makes the abstraction of
a proton from the C3 position less favorable. Presumably,
His194 and Gln329, together with the essential MgII ion, polar-
ize the C4 carboxylate group and stabilize the enolate anion
Figure 4. Close-up view of two superimposed active sites of C. amalonaticus
MAL, one in complex with the natural substrate (2S,3S)-3-methylaspartic acid
(2)[13] (shown in gray) and the other with the most-favored conformation of
the modeled nonnatural substrate (2S,3R)-3-methylaspartic acid (3) (shown
in cyan). The orientation of 2 suggests that its C3 proton is abstracted by
Lys331, whereas the orientation of 3 suggests that its C3 proton is abstract-
ed by His194. The figure was prepared with Discovery Studio 1.7.
Scheme 3. A schematic representation of the proposed catalytic mechanism of MAL, showing the key participants
in the deamination of (2S,3S)-3-methylaspartic acid.
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intermediate 4 that is formed upon abstraction of the C3
proton (Scheme 3). An electrophilic residue, the role of which
is to assist the MgII ion in providing the charge neutralization
that is essential for the activation of the a proton and for stabi-
lizing the enolate anion intermediate, has also been identified
in mandelate racemase (Lys164) and some other enolase su-
perfamily members.[14,19]
In addition to its presumed role as electrophilic residue,
His194 might also function as the R-specific base/acid catalyst.
Naismith and co-workers first proposed this role for His194
based on structure comparisons of enolase superfamily mem-
bers.[12] The sidechain of His194 superimposes on that of the
second base Lys166 in mandelate racemase and the principal
base Lys213 in glucarate dehydratase.[12] Moreover, if the three-
dimensional structure of 3 is modeled into the active site of
MAL by using the X-ray structure of MAL in complex with 2 as
a guide, then the C3 proton of 3 is faced towards the imida-
zole nitrogen atom (Ne2) of His194 (Figure 4). Our experiments
clearly show that His194 is an important determinant of the
stereoselectivity of MAL because an alanine mutation at this
position results in a mutant enzyme that appears to have lost
its ability to catalyze proton abstraction/addition from the R
face (the His194 side) of the substrate. Indeed, the H194A
mutant has no detectable deamination activity with 3 and cat-
alyzes the highly stereoselective conversion of 1 to 2, with no
detectable formation of 3. Taken together, these observations
are consistent with a role of His194 as the R-specific general
base catalyst for the deamination of 3 and, hence, as the acid
catalyst (the conjugate acid of His194) in the corresponding
ACHTUNGTRENNUNGreverse syn-addition reaction.
In view of the presumed role of His194 as the R-specific gen-
eral base/acid catalyst, mutation of Lys331 or Gln329 to an ala-
nine gave results that were somewhat unexpected. Initially, it
was thought that mutation of Lys331 would only effect proton
abstraction/addition from the S face (the Lys331 side) of the
substrate. Surprisingly, however, the K331A mutant lost its abil-
ity to catalyze proton abstraction/addition from the R face of
the substrate, but it retained a very low-level proton abstrac-
tion/addition activity from the S face of the substrate. Like
K331A, the Q329A mutant also catalyzes the highly stereose-
lective conversion of 1 to 2 with no detectable formation of 3.
But, in contrast to K331A, the Q329A mutant still has a detect-
able low-level deamination activity with 3.
One potential explanation for the alteration in diastereose-
lectivity of the K331A and Q329A mutants is that mutation of
Lys331 or Gln329 to an alanine causes different interactions be-
tween substrate and enzyme and might influence the geome-
try of a Michaelis complex that undergoes proton abstraction/
addition from the R face of the substrate. In this scenario, the
removal of the native interactions with the substrate places
the substrate in an unfavorable position to undergo proton
ACHTUNGTRENNUNGabstraction/addition by His194, the presumed R-specific base/
acid catalyst. Another explanation for the loss in proton ab-
straction/addition activity from the R face of the substrate is
that mutation of Lys331 or Gln329 by an alanine directly influ-
ences the orientation of the His194 sidechain. Crystallographic
studies of the H194A, K331A, and Q329A mutants, and of wild-
type MAL in complex with 3, would be an important step
toward understanding how these mutations affect the stereo-
chemical properties of MAL.
The current investigation has clearly demonstrated that the
stereoselectivity of MAL can be enhanced by mutation of the
active-site residues His194, Lys331, and Gln329. Interestingly,
the mutation of Gln73 or Gln172, two residues implicated in
binding the C2 amino group of 2 (Figure 4), to an alanine has
a profound effect on the values of kcat and kcat/KM (with 1 and
2) but no significant effect on the stereoselectivity of MAL.
Like wild-type MAL, the Q73A and Q172A mutants catalyze the
amination of 1 to give both 2 and 3 as products (H.R. , G.J.P. ,
unpublished results, 2009). Hence, His194, Gln329, and Lys331
appear to be the major determinants of the stereoselectivity of
MAL. The enhancement of the stereoselectivity should make it
possible to utilize single amino acid variants of MAL (e.g. ,
H194A) in stereo- and regioselective amination reactions to
produce 3-substituted aspartic acid isomers with a very high
diastereomeric excess. Such efforts are being pursued in our
laboratories.
Experimental Section
Materials : dl-threo-3-methylaspartic acid, mesaconic acid, and l-
arabinose were purchased from Sigma–Aldrich. (2S,3R)-3-Methylas-
partic acid (95% purity) was purchased from Syncom (Groningen,
The Netherlands). Ingredients for buffers and media were obtained
from Duchefa Biochemie (Haarlem, The Netherlands) or Merck. Mo-
lecular biology reagents, including restriction enzymes, PCR re-
agents, T4 DNA ligase, DNA ladders, agarose, and protein molecu-
lar weight standards were obtained from F. Hoffmann–LaRoche,
Promega, Invitrogen, Finnzymes (Espoo, Finland) or New England
Biolabs. PCR purification, gel extraction, and Miniprep kits were
provided by Macherey–Nagel (Dren, Germany). Pre-packed PD-10
Sephadex G-25 columns were purchased from GE Healthcare Bio-
Sciences. Oligonucleotides for DNA amplification were synthesized
by Operon Biotechnologies (Cologne, Germany).
Bacterial strains, plasmids, and growth conditions : E. coli strain
XL1-Blue (Stratagene, La Jolla, CA) was used for cloning and isola-
tion of plasmids. E. coli strain TOP10 (Invitrogen) was used in com-
bination with the pBAD/Myc-His A vector (Invitrogen) for recombi-
nant protein production. C. tetanomorphum ATCC 15920, the ge-
nomic DNA source for the MAL gene, was purchased from DSMZ
GmbH (Braunschweig, Germany). E. coli cells were grown in Luria–
Bertani (LB) media. When required, Difco agar (15 g/L), ampicillin
(Ap, 100 mgmL1), and/or arabinose (0.004% w/v) were added to
the medium.
General methods : Techniques for restriction enzyme digestions, li-
gation, transformation, and other standard molecular biology ma-
nipulations were based on methods described elsewhere[20] or as
suggested by the manufacturer. The PCR was carried out in a DNA
thermal cycler (model GS-1) obtained from Biolegio (Nijmegen, The
Netherlands). DNA sequencing was performed by ServiceXS
(Leiden, The Netherlands) or Macrogen (Seoul, Korea). Protein was
analyzed by PAGE under either denaturing conditions by using
SDS or native conditions on gels containing polyacrylamide (7.5–
10%). The gels were stained with Coomassie brilliant blue. Protein
concentrations were determined by the Waddell method.[21] Kinetic
data were obtained on a V-650 spectrophotometer from Jasco
(IJsselstein, The Netherlands). The solutions in the cuvettes were
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mixed by using a stir/add cuvette mixer (Bel-Art Products, Pequan-
nock, NJ, USA). The kinetic data were fitted by nonlinear regression
data analysis by using the Grafit program (Erithacus, Software Ltd. ,
Horley, UK) obtained from Sigma Chemical Co. The CD spectra
were recorded on a model 62A-DS spectropolarimeter from AVIV
Biomedical Inc. (Lakewood, NJ, USA). 1H NMR spectra were record-
ed on a Varian Inova 500 (500 MHz) spectrometer by using a pulse
sequence for selective presaturation of the water signal. Chemical
shifts for protons are reported in parts per million scale (d scale)
downfield from tetramethylsilane and are referenced to protium
(H2O: d=4.67).
Construction of the expression vector for the production of
MAL : The MAL gene was amplified by PCR by using two synthetic
primers, a small amount of biomass from C. tetanomorphum as the
genomic DNA source, and the PCR reagents supplied in the
Expand High Fidelity PCR system by following the protocol sup-
plied with the system (F. Hoffmann-La Roche, Ltd.). The forward
primer (5’-ATA CAT ATG AAA ATT GTT GAC GTA CTT TG-3’) contains
a NdeI restriction site (in bold) followed by 20 bases corresponding
to the coding sequence of the MAL gene. The reverse primer (5’-
CAT AAG CTT TTT TCT TCT TCC TAC AAG-3’) contains a HindIII re-
striction site (in bold) followed by 18 bases corresponding to the
complementary sequence of the MAL gene. The resulting PCR
product and the pBADN/Myc-His A vector were digested with NdeI
and HindIII restriction enzymes, purified, and ligated by using T4
DNA ligase. The pBADN/Myc-His A vector is a variant of the com-
mercially available pBAD/Myc-His A vector in which the unique
NcoI site is replaced with NdeI.[22] Aliquots of the ligation mixture
were transformed into competent E. coli TOP10 cells. Transformants
were selected at 37 8C on LB/Ap plates. Plasmid DNA was isolated
from several colonies and analyzed by restriction analysis for the
presence of the insert. The cloned MAL gene was sequenced to
verify that no mutations had been introduced during the amplifica-
tion of the gene. The newly constructed expression vector was
named pBAD ACHTUNGTRENNUNG(MAL-His).
Construction of MAL mutants : Mutants of MAL were generated
by the overlap extension PCR method[23] by using plasmid pBAD-
ACHTUNGTRENNUNG(MAL-His) as the template. The final PCR products were gel puri-
fied, digested with the NdeI and HindIII restriction enzymes, and
ACHTUNGTRENNUNGligated in-frame with both the initiation ATG start codon and the
sequence that codes for the polyhistidine region of the expression
vector pBADN/Myc-His A. All mutant genes were completely se-
quenced (with overlapping reads) to verify that only the intended
mutation had been introduced.
Expression and purification of MAL wild type and mutants : The
MAL enzyme, either wild type or mutant, was produced in E. coli
TOP10 by using the pBAD expression system. Fresh TOP10 cells
containing the appropriate expression plasmid were collected from
a LB/Ap plate by using a sterile loop and used to inoculate LB/Ap
medium (15 mL). After growth for 8 h at 37 8C, a sufficient quantity
of the culture was used to inoculate fresh LB/Ap medium (300 mL)
containing arabinose (0.004%, w/v) in a 1 L Erlenmeyer flask to an
initial A600 of ~0.1. Cultures were grown for 4 d at 17 8C with
ACHTUNGTRENNUNGvigorous shaking. Cells were harvested by centrifugation (6000g,
15 min) and stored at 20 8C until further use.
In a typical purification experiment, cells (of three 300 mL cultures)
were thawed, combined, and suspended in lysis buffer (10 mL,
50 mm NaH2PO4, 300 mm NaCl, 10 mm imidazole, pH 8.0). Cells
were disrupted by sonication for 41 min (with 4–6 min rest in be-
tween each cycle) at a 60 W output, after which unbroken cells
and debris were removed by centrifugation (10000g, 45 min). The
supernatant was filtered through a 0.45 mm pore diameter filter
and incubated with Ni-NTA (1 mL slurry in a small column at 4 8C
for 18 h), which had previously been equilibrated with lysis
buffer. The nonbound proteins were eluted from the column by
gravity flow. The column was first washed with lysis buffer (10 mL)
and then with buffer A (50 mm NaH2PO4, 300 mm NaCl, 20 mm imi-
dazole, pH 8.0; 10 mL). Retained proteins were eluted with buffer B
(50 mm NaH2PO4, 300 mm NaCl, 250 mm imidazole, pH 8.0; 2.0 mL).
Fractions (~0.5 mL) were analyzed by SDS-PAGE on gels containing
acrylamide (10%), and those that contained purified MAL were
combined and the buffer was exchanged against Tris buffer
(50 mm, pH 8.0), containing MgCl2 (2 mm) and KCl (0.1 mm), by
using a prepacked PD-10 Sephadex G-25 gel filtration column. The
purified enzyme was stored at +4 8C or 80 8C until further use.
Circular dichroism spectroscopy : Circular dichroism spectra of the
wild-type protein and the purified mutants were measured in Tris–
HCl buffer (10 mm, pH 8.0), containing MgCl2 (2 mm) and KCl
(0.1 mm), at a concentration of approximately 3.2 mm in a CD cell
with a 1.0 mm optical path length.
Kinetic assays : The assays used for the spectrophotometric deter-
mination of the deamination of 2 and to follow the amination of 1
are based on protocols reported elsewhere.[3] Accordingly, the de-
amination of 2 by MAL was monitored by following the formation
of 1 at 240 nm (e=3850m1 cm1) in Tris–HCl buffer (500 mm,
pH 9.0) containing MgCl2 (20 mm) and KCl (1 mm) at 30 8C. An ali-
quot of MAL, either wild type or mutant, was diluted into buffer
(20 mL) and incubated for 30 min at 30 8C. The 30 min equilibration
period resulted in more reproducible kinetic data. Subsequently, a
portion (1 mL) was transferred to a 10 mm quartz cuvette and the
enzyme activity was assayed by the addition of a small quantity
(1–10 mL) of 2 from a stock solution. The stock solutions were
made up by dissolving the appropriate amount of dl-threo-3-
methylaspartic acid (a 1:1 mixture of the enantiomers (2S,3S)-3-
methylaspartic acid and (2R,3R)-3-methylaspartic acid) in Tris–HCl
buffer (500 mm, pH 9.0) to obtain the desired concentration of 2.
The (2R,3R)-enantiomer is neither a substrate nor an inhibitor of
MAL. The concentrations of 2 that were used in the assay ranged
from 0.5 to 20 mm.
The rate of amination of 1 was monitored by following the deple-
tion of 1 at 270 nm (e=482m1 cm1) in Tris–HCl buffer (500 mm,
pH 9.0) containing MgCl2 (20 mm) and NH4Cl (400 mm) at 30 8C.
[3]
An aliquot of MAL, either wild-type or mutant, was diluted into
buffer (20 mL) and incubated for 30 min at 30 8C. Subsequently, a
portion (1 mL) was transferred to a 1 or 10 mm quartz cuvette and
the enzyme activity was assayed by the addition of a small quanti-
ty (1–10 mL) of 1 from a stock solution. The stock solutions were
made up in Tris–HCl buffer (500 mm, pH 9.0). The concentrations
of 1 that were used in the assay ranged from 0.1 to 50 mm.
pH dependence of the kinetic parameters of MAL and H194A :
The pH dependence of the steady-state kinetic parameters was de-
termined in Tris buffer (500 mm) containing MgCl2 (20 mm) and KCl
(1 mm) with pH values ranging from 6.0–9.5. For each pH value, a
sufficient quantity of enzyme (from a stock solution in Tris buffer
(50 mm, pH 8.0) containing 2 mm MgCl2 and 0.1 mm KCl) was equi-
librated in buffer (20 mL) for 30 min at 30 8C. The addition of
enzyme did not significantly change the pH. Subsequently, aliquots
(1 mL) were removed and assayed for activity by using concentra-
tions of 2 ranging from 0.5–50 mm. Stock solutions of 2 were
made in Tris buffer (500 mm). The pH of the stock solutions was
adjusted to each desired pH value (6.0–9.5). The volume of sub-
strate added was 20 mL or less in all experiments.
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1H NMR spectroscopic product analysis of the amination of 1 by
MAL wild type and mutants : The products of the amination of 1
by wild-type MAL and the MAL mutants were identified by 1H NMR
spectroscopy by using a procedure described elsewhere[2] with the
following modifications. In separate experiments, MAL, K331A,
H194A, or Q329A was incubated with 1, and the reactions were
ACHTUNGTRENNUNGfollowed by 1H NMR spectroscopy. Reaction mixtures consisted of
Na2HPO4 buffer (350 mL; 100 mm, containing 20 mm MgCl2 and
1 mm KCl, pH 9.0), D2O (50 mL), NH4Cl (100 mL, 5m), and an aliquot
of 1 (100 mL) from a 500 mm stock solution. The stock solution of 1
was made in Na2HPO4 buffer (100 mm), and the pH of the solution
was adjusted to 9.0 with aliquots of an aq 1m NaOH solution. A
quantity of enzyme (50 mL) was added from a stock solution and
the reaction mixtures were incubated at 22 8C. The concentrations
of the protein stock solutions were MAL (12.3 mgmL1), K331A
(13.4 mgmL1), H194A (10.7 mgmL1), and Q329A (14.4 mgmL1).
Additional aliquots of enzyme (50 mL) were added to the individual
mixtures after 3, 6, 9, and 12 days. 1H NMR spectra were recorded
1 h, 3 d, 7 d, and 13 d after the first addition of enzyme. Product
amounts were estimated by integration of the signals correspond-
ing to 2 and 3, if present. The 1H NMR signals for 1, 2, and 3 are
given in the Supporting Information (Figures S1, S2 and S3).
1H NMR spectroscopic product analysis of the reaction of wild-
type and mutant MAL with 2 or 3 : The products of the deamina-
tion of 2 or 3 by wild-type MAL and the MAL mutants were identi-
fied by 1H NMR spectroscopy. In separate experiments, MAL,
K331A, H194A or Q329A was incubated with 2 or 3. Reaction mix-
tures consisted of Na2HPO4 buffer (400 mL; 100 mm, containing
20 mm MgCl2 and 1 mm KCl, pH 9.0), D2O (40 mL), and an aliquot of
2 or 3 (150 mL) from a 500 mm stock solution. The stock solutions
of 2 and 3 were made in Na2HPO4 buffer (100 mm), and the pH of
the solutions was adjusted to 9.0 with aliquots of a 1m aq NaOH
solution. A quantity of enzyme (50 mL) was added from a stock
ACHTUNGTRENNUNGsolution and the reaction mixtures were incubated at 22 8C. The
concentrations of the protein stock solutions were MAL
(15.7 mgmL1), K331A (12.8 mgmL1), H194A (7.4 mgmL1), and
Q329A (8.8 mgmL1). Additional aliquots of enzyme (50 mL) were
added to the individual mixtures after 3, 6, 9, and 12 d. The eight
reaction mixtures were examined by 1H NMR spectroscopy after a
13-day incubation period, and the product amounts were estimat-
ed by integration of the signals corresponding to 1, 2 and 3, if
present.
Molecular docking : Comparative docking simulations were per-
formed by using Discovery Studio 1.7 (Accelrys, San Diego, CA,
USA). Models for the enzymes were based on the structures of
C. amalonaticus MAL in complex with 2[13] and C. tetanomorphum
MAL in the absence of a bound ligand[12] (PDB IDs: 1KKR and 1KCZ,
respectively). Hydrogen atoms were added automatically. Models
of the substrates were constructed, and the energy was minimized
by using the CHARMm force field.[24] Minimization was done by
using a dielectric constant of one and a nonbonded cutoff distance
of 12 . The substrates were docked by using the grid-based ap-
proach CDOCKER, a molecular dynamics (MD) simulated-annealing-
based algorithm,[25,26] by using the experimentally determined
binding site for 2 in C. amalonaticus MAL as coordinates. Initially,
the enzyme active site was fixed, and the atoms of the substrate,
either 2 or 3, were allowed to move. For subsequent rounds of
minimization, the constraints on the amino acids forming the
active site were removed and replaced by distance constraints
based on the reported distances observed in X-ray structure of
MAL complexed with 2. A final minimization step was applied to
each ligand-docked pose that consisted of 300 steps of steepest
descent followed by 2500 iterations of the adopted basis-set
Newton–Raphson algorithm with an energy tolerance of 0.001 Kcal
mol1.
Abbreviations : Ap, ampicillin; CD, circular dichroism; LB, Luria–Ber-
tani; MAL, 3-methylaspartate ammonia-lyase.
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